| Target Price | €16.32 |
| Price | €14.40 |
| Potential |
13.33%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Rhön Klinikum 2027 .
The average Rhön Klinikum target price is €16.32.
This is
13.33%
register free of charge
€16.80
16.67%
register free of charge
€16.16
12.22%
register free of charge
|
|
| A rating was issued by 7 analysts: 4 Analysts recommend Rhön Klinikum to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Rhön Klinikum stock has an average upside potential 2027 of
13.33%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion € | 1.70 | 1.81 |
| 6.84% | 6.12% | |
| EBITDA Margin | 6.22% | 6.81% |
| 10.70% | 9.52% | |
| Net Margin | 2.02% | 2.32% |
| 25.57% | 14.74% |
4 Analysts have issued a sales forecast Rhön Klinikum 2026 . The average Rhön Klinikum sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Rhön Klinikum EBITDA forecast 2026. The average Rhön Klinikum EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Rhön Klinikum Analysts have issued a net profit forecast 2026. The average Rhön Klinikum net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share € | 0.52 | 0.63 |
| 20.00% | 21.15% | |
| P/E | 23.00 | |
| EV/Sales | 0.28 |
4 Analysts have issued a Rhön Klinikum forecast for earnings per share. The average Rhön Klinikum EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| LANDESBANK BADEN-WUERTTEMBERG |
Locked
➜
Locked
|
Locked | May 14 2026 |
| SOLVENTIS RESEARCH |
Locked
➜
Locked
|
Locked | Feb 17 2026 |
| SOLVENTIS RESEARCH |
Locked
➜
Locked
|
Locked | Feb 16 2026 |
| LANDESBANK BADEN-WUERTTEMBERG |
Locked
➜
Locked
|
Locked | Nov 19 2025 |
| LANDESBANK BADEN-WUERTTEMBERG |
Locked
➜
Locked
|
Locked | Mar 31 2025 |
| LANDESBANK BADEN-WUERTTEMBERG |
Locked
➜
Locked
|
Locked | Mar 30 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
LANDESBANK BADEN-WUERTTEMBERG:
Locked
➜
Locked
|
May 14 2026 |
|
Locked
SOLVENTIS RESEARCH:
Locked
➜
Locked
|
Feb 17 2026 |
|
Locked
SOLVENTIS RESEARCH:
Locked
➜
Locked
|
Feb 16 2026 |
|
Locked
LANDESBANK BADEN-WUERTTEMBERG:
Locked
➜
Locked
|
Nov 19 2025 |
|
Locked
LANDESBANK BADEN-WUERTTEMBERG:
Locked
➜
Locked
|
Mar 31 2025 |
|
Locked
LANDESBANK BADEN-WUERTTEMBERG:
Locked
➜
Locked
|
Mar 30 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


